Skip to main content

Luca Bollo

Institutions of which they are part

Predoctoral researcher
Clinical Neuroimmunology
Vall Hebron Institut de Recerca

Luca Bollo

Institutions of which they are part

Predoctoral researcher
Clinical Neuroimmunology
Vall Hebron Institut de Recerca

Projects

Mecanismos subyacentes del daño axonal y discapacidad en enfermedad asociada a anticuerpos anti-MOG: Estudio MOGAXON

IP: Alvaro Cobo Calvo
Collaborators: Cristina Auger Acosta, Miguel Angel Robles Sanchez, Elisa Marín Ordovás, Mireia Castillo Juarez, Luca Bollo
Funding agency: Instituto de Salud Carlos III
Funding: 201875
Reference: PI24/00859
Duration: 01/01/2025 - 31/12/2027

Related news

Anti-Müllerian hormone had been proposed as a potential biomarker for predicting disease prognosis in women, but this study shows that the observed association is explained by patients’ chronological age.

The Spider-MS tool estimates the probability that a patient will experience various long-term clinical events and will help personalize the follow-up and treatment of each person living with the disease.

The results show that live attenuated vaccines against measles, rubella, mumps and varicella do not increase the risk of relapses in people with multiple sclerosis.

Related professionals

Maria Angeles Jiménez Fuentes

Maria Angeles Jiménez Fuentes

Predoctoral researcher
Pneumology
Read more
María Escribano Cebrián

María Escribano Cebrián

Predoctoral researcher
Head and Neck Cancer: Biomedical Research Cancer Stem cells
Read more
Marta Codina Solà

Marta Codina Solà

Postdoctoral researcher
Genetics Medicine
Read more
María Consuelo Moncayo Zambrano

María Consuelo Moncayo Zambrano

Postdoctoral researcher
Reconstructive Surgery of the Locomotor System
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.